Top Analyst Upgrades and Downgrades: Arch Coal, Editas, FireEye, Generac, NextEra, Under Armour and More

Investing

Published: September 7, 2017 9:00 am

Last Updated: March 20, 2020 11:16 am

Stocks were looking for direction on Thursday. After a debt ceiling deal was reached on Wednesday, the European Central Bank kept rates flat and maintained an outlook of lower rates for an extended period. Investors have to keep in mind that the major stock indexes still remain close to all-time highs, and they also have to consider that investors keep finding new reasons to buy stocks after every sell-off. Many of those same investors are also looking for new investing and trading ideas to generate gains and income.

24/7 Wall St. reviews dozens of analyst research reports each day of the week. Our goal is to find new investing and trading ideas for our readers. Some of the top analyst reports cover stocks to buy, while some are reiterations of ratings with target changes. And some of these calls even cover stocks to sell or to avoid.

Additional color and commentary has been added on most of the daily analyst calls. Consensus analyst price target data are from the Thomson Reuters sell-side research service.

These were the top analyst upgrades, downgrades and other research calls from Thursday, September 7, 2017.

Arch Coal Inc. (NYSE: ARCH) was started as Neutral with an $84 price target (after closing up 2% at $78.22) at Macquarie. The stock has a 52-week range for closing prices of about $61.70 to $84.79, and it has a consensus analyst price target of $97.57.

Editas Medicine Inc. (NASDAQ: EDIT) was started as Overweight with a $28 price target (versus a $19.69 prior close) at Barclays. It has a 52-week range of $12.43 to $29.20 and a consensus price target of $35.25. Editas is still up about $1 from its earnings report in August, but it was up above $23 briefly after that earnings report.

FireEye Inc. (NASDAQ: FEYE) was raised to Overweight from Equal Weight with a $19 price target (versus a $14.78 close) at Morgan Stanley. The 52-week range is $10.35 to $16.40 and the consensus price target is $16.41.

Generac Holdings Inc. (NYSE: GNRC) was raised to Neutral from Underperform with a $45 price objective (after closing up 3.6% at $43.59) at Merrill Lynch, with the firm noting that an inability to predict weather demand after a weaker power outage impact on Houston was why it has that rating. Shares were last indicated up 1% at $44.00, in a 52-week range of $33.77 to $44.84 and with a consensus analyst target of $40.33.

NextEra Energy Inc. (NYSE: NEE) was started as Overweight and assigned a $173 price target (versus a $148.25 close) at JPMorgan. NextEra has a 52-week range of $110.49 to $151.30 and a consensus price target of $154.08.

Under Armour Inc. (NYSE: UAA) was reiterated as Buy with a $28 target price (versus a $16.76 close) at Jefferies. On top of being well positioned in a challenging North American backdrop, the firm feels that its strategic goals prioritize increased diversification, optimized distribution and streamlined corporate infrastructure enough for the brand to have a sound plan for outpacing industry growth.

ALSO READ: JPMorgan Out With 3 Top Internet Picks for the Rest of 2017

Follow @Jonogg on Twitter to receive the daily analyst calls and other market research calls directly on your feed.

Other key analyst calls were seen in the following:

Agile Therapeutics Inc. (NASDAQ: AGRX) was reiterated as Buy with a $13 fair value estimate (versus a $3.34 close) at Janney. The firm noted that its Twirla just as effective as FDA-approved contraceptives.

AstraZeneca PLC (NYSE: AZN) was started as Outperform with a $38 price target at BMO Capital Markets.

Carrizo Oil & Gas Inc. (NASDAQ: CRZO) was downgraded to Neutral from Outperform with a $17 price target (versus a $13.26 close) at Mizuho.

C&J Energy Services Inc. (NYSE: CJ) was started with a Buy rating and assigned a $37 price target (versus a $27.50 close) at Guggenheim.

Esperion Therapeutics Inc. (NASDAQ: ESPR) was started as Outperform with a $64 price target (versus a $49.27 a close) at Cowen.

Group 1 Automotive Inc. (NYSE: GPI) was raised to Neutral from Sell with a $67 price target (versus a $62.30 close) at Goldman Sachs.

JELD-WEN Holding Inc. (NYSE: JELD) was raised to Buy from Neutral and the price objective was raised to $40 from $36 (versus a $32.23 close) at Merrill Lynch.

24/7 Wall St.
How Hurricane Harvey Rebuilding Could Boost 4 Great Companies

Match Group (NASDAQ: MTCH) was reiterated as Buy and the price target was raised to $28 from $23 (versus a $23.27 close) at Jefferies.

Navistar International Corp. (NYSE: NAV) was reiterated as Buy and the price target was raised to $47 from $35 (versus a $36.29 close) at Jefferies.

Pan American Silver Corp. (NASDAQ: PAAS) was started with a Buy rating and assigned a $22 price target (versus an $18.78 close) at Canaccord Genuity.

Playa Hotels & Resorts N.V. (NASDAQ: PLYA) was started with a Buy rating and assigned a $14 fair value estimate (versus a $10.76 close) at Janney.

Praxair Inc. (NYSE: PX) was raised to Positive from Neutral with a $155 price target (versus a $131.77 close) at Susquehanna.

RH (NYSE: RH) was raised to Buy from Neutral with an $88 price target (versus a $49.42 close) at Buckingham Research.

Restaurant Brands International Inc. (NYSE: QSR) was raised to Outperform from Neutral with a $74 price target (versus a $60.51 close) at Credit Suisse.

Sealed Air Inc. (NYSE: SEE) was downgraded to Neutral from Buy with a $47 price target (versus a $43.44 close) at Citigroup.

Shiloh Industries Inc. (NASDAQ: SHLO) was started as Neutral with a $9.50 price objective (versus an $8.90 close) at Merrill Lynch.

Trivago N.V. (NASDAQ: TRVG) was downgraded to Neutral from Buy at Merrill Lynch. This stock fell 16% to $12.49 on Wednesday after lower growth and marketing efficiency predictability. Its 52-week range is now $10.43 to $24.27.

Varian Medical Systems Inc. (NYSE: VAR) was downgraded to Neutral from Buy at BTIG.

WEC Energy Group Inc. (NYSE: WEC) was reiterated as Buy and the price target was raised to $70 from $67 (versus a $65.58 close) at Argus. It also has a 3.2% dividend yield.

Wednesday’s top analyst upgrades and downgrades included BioCryst Pharmaceuticals, Exxon Mobil, Fiat Chrysler Automobiles, Hewlett Packard Enterprise, IAMGOLD, Mallinckrodt, Rockwell Collins and many more.

Credit card companies are handing out rewards and benefits to win the best customers. A good cash back card can be worth thousands of dollars a year in free money, not to mention other perks like travel, insurance, and access to fancy lounges. See our top picks for the best credit cards today. You won’t want to miss some of these offers.

Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.